Page last updated: 2024-12-07

3'-uridylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

UMP is a nucleotide that serves as a building block for RNA. It consists of the pyrimidine base uracil attached to a ribose sugar, which is then linked to a phosphate group at the 3' carbon of the ribose. UMP plays a crucial role in numerous metabolic processes, including RNA synthesis, energy metabolism, and the biosynthesis of other nucleotides. It is also an essential component of the genetic code. In research, UMP is studied for its involvement in a range of biological processes, such as gene expression, cell signaling, and the regulation of metabolism. The synthesis of UMP occurs through the salvage pathway, where pre-existing uracil is converted to UMP. Alternatively, UMP can be synthesized de novo from the precursor orotate. UMP can be phosphorylated to form UDP and UTP, which are also important nucleotides involved in various metabolic pathways.'

3'-uridylic acid: structure in first source; main heading URIDINE MONOPHOSPHATE refers to 5'-uridylic acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3'-UMP : A pyrimidine ribonucleoside 3'-monophosphate having uracil as the nucleobase. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID101543
CHEMBL ID460741
CHEBI ID28895
SCHEMBL ID345577
MeSH IDM0097815

Synonyms (27)

Synonym
3'-uridylic acid
CHEBI:28895 ,
u3p ,
3'-uridinemonophosphate
uridine 3'-phosphate
C01368
3'-ump
uridine 3'-monophosphate
DB02714
4RSK
1O0N
CHEMBL460741 ,
[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate
3''-uridylic acid
3''-ump
bdbm50292722
uridine 3'-(dihydrogen phosphate)
einecs 201-538-0
unii-zi74vyb8vz
zi74vyb8vz ,
SCHEMBL345577
uracylsaure
uridine-3'-phosphate
Q27103948
DTXSID401018973
3-umpna
PD042601
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
uridine phosphate
pyrimidine ribonucleoside 3'-monophosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (11)

PathwayProteinsCompounds
Pyrimidine Ribonucleosides Degradation511
Disease1278231
Infectious disease89579
SARS-CoV Infections28229
SARS-CoV-1 Infection11422
SARS-CoV-2 Infection19527
SARS-CoV-2 Genome Replication and Transcription710
Replication of the SARS-CoV-2 genome59
Early SARS-CoV-2 Infection Events2811
SARS-CoV-1 activates/modulates innate immune responses414
Viral Infection Pathways72739

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ribonuclease pancreaticBos taurus (cattle)Ki82.00001.200024.050082.0000AID977610
Chain A, Ribonuclease pancreaticBos taurus (cattle)Ki82.00001.200024.050082.0000AID977610
Chain A, Ribonuclease pancreaticBos taurus (cattle)Ki82.00001.200024.050082.0000AID977610
Chain A, Ribonuclease pancreaticBos taurus (cattle)Ki82.00001.200024.050082.0000AID977610
Chain A, Ribonuclease pancreaticBos taurus (cattle)Ki82.00001.200024.050082.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ribonuclease ABos taurus (cattle)Kd47.400047.400047.400047.4000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
defense response to virusSeminal ribonucleaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
nucleic acid bindingSeminal ribonucleaseBos taurus (cattle)
ribonuclease A activitySeminal ribonucleaseBos taurus (cattle)
RNA nuclease activitySeminal ribonucleaseBos taurus (cattle)
lyase activitySeminal ribonucleaseBos taurus (cattle)
identical protein bindingSeminal ribonucleaseBos taurus (cattle)
nucleic acid bindingRibonuclease pancreaticBos taurus (cattle)
ribonuclease A activityRibonuclease pancreaticBos taurus (cattle)
protein bindingRibonuclease pancreaticBos taurus (cattle)
lyase activityRibonuclease pancreaticBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
extracellular regionSeminal ribonucleaseBos taurus (cattle)
extracellular regionRibonuclease pancreaticBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID469231Inhibition of bovine pancreatic ribonuclease A assessed as enzyme activity by spectrophotometric method pH 62009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.
AID469230Inhibition of bovine seminal ribonuclease assessed as enzyme activity by spectrophotometric method at pH 62009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.
AID345848Inhibition of bovine pancreatic RNase A by spectrophotometric method2009Journal of medicinal chemistry, Feb-26, Volume: 52, Issue:4
Morpholino, piperidino, and pyrrolidino derivatives of pyrimidine nucleosides as inhibitors of ribonuclease A: synthesis, biochemical, and crystallographic evaluation.
AID1811Experimentally measured binding affinity data derived from PDB1998Biochemistry, Dec-15, Volume: 37, Issue:50
Coulombic effects of remote subsites on the active site of ribonuclease A.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1998Biochemistry, Dec-15, Volume: 37, Issue:50
Coulombic effects of remote subsites on the active site of ribonuclease A.
AID1811Experimentally measured binding affinity data derived from PDB2003Protein science : a publication of the Protein Society, Nov, Volume: 12, Issue:11
High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2003Protein science : a publication of the Protein Society, Nov, Volume: 12, Issue:11
High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (16.67)18.7374
1990's1 (8.33)18.2507
2000's5 (41.67)29.6817
2010's3 (25.00)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]